Table 1.
Age | Gender | Symptoms | Onset | First-line therapy | Second-line therapy | Fecal bacterial culture | DLST | References |
---|---|---|---|---|---|---|---|---|
58 | F | Abdominal pain, bloody diarrhea | 8 days after starting eradication | CAM + AMPC + RPZ | MNZ 500 mg + AMPC 1500 mg + RPZ 20 mg | Pathogenic bacteria was not detected | Not described | #12 |
54 | M | Abdominal pain, bloody diarrhea | 7 days after starting eradication | CAM + AMPC + RPZ | MNZ 500 mg + AMPC 1500 mg + RPZ 20 mg | Pathogenic bacteria was not detected | Not described | #12 |
59 | F | Abdominal pain, bloody diarrhea | 9 days after starting eradication | CAM + AMPC + RPZ | MNZ 500 mg + AMPC 1500 mg + RPZ 20 mg | Pathogenic bacteria was not detected | Not described | #12 |
60 | F | Abdominal pain, bloody diarrhea | 9 days after starting eradication | CAM + AMPC + PPI | MNZ + AMPC + PPI | Klebsiella oxytoca | Not described | #13 |
50 | M | Abdominal pain, hematochezia | 6 days after starting eradication | CAM + AMPC + PPI | MNZ + AMPC + PPI | Not described | Not described | #13 |
65 | F | Abdominal pain, hematochezia | 8 days after starting eradication | CAM 800 mg + AMPC 1500 mg + LPZ 60 mg | MNZ 500 mg + AMPC 1500 mg + Vonoprazan 40 mg | Klebsiella oxytoca | Positive for both AMPC and MNZ | Present case |
CAM clarithromycin, AMPC amoxicillin, MNZ metronidazole, RPZ rabeprazole, LPZ lansoprazole, PPI proton pump inhibitor